Since incorporating the Spectralis OCT into his routine assessments, optometrist Paul Adler has identified a number of clinical and non-clinical areas that have benefited. Clinically, Adler feels he is less likely to miss pathology, is better able to monitor conditions, is more confident in reassuring patients about their eye health and makes more reliable diagnostic decisions. Non-clinical benefits include perceived prestige, better patient interest and involvement, and improved staff involvement and motivation.
Potential challenges include the initial cost and Adler emphasises the importance of thinking about finance and developing a business model from the start. ‘Calculate the cost per patient,’ he advises from the word go. Staff training is another essential and, despite extra constraints on time, ensure that the clinical and non-clinical benefits are fully realised.
Register now to continue reading
Thank you for visiting Optician Online. Register now to access up to 10 news and opinion articles a month.
Register
Already have an account? Sign in here